Islet autoantibody measurements from dried blood spots on filter paper strongly correlate to serum levels

PLoS ONE

Volumn 11, Issue 11, 2016, Pages

  Simmons, Kimber M ^a   Alkanani, Aimon K ^a   McDaniel, Kristen A ^a   Goyne, Christopher ^b   Miao, Dongmei ^a   Zhao, Zhiyuan ^a   Yu, Liping ^a   Michels, Aaron W ^a  

^a UNIVERSITY OF COLORADO DENVER   (United States)

^b INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; GLUTAMATE DECARBOXYLASE ANTIBODY; INSULIN ANTIBODY; UNCLASSIFIED DRUG; ZINC TRANSPORTER; ZINC TRANSPORTER 8 AUTOANTIBODY;

ADOLESCENT; ADULT; AGED; ANTIBODY BLOOD LEVEL; ARTICLE; CHILD; CONTROLLED STUDY; DRIED BLOOD SPOT TESTING; FEMALE; FILTER; FILTER PAPER; FIRST-DEGREE RELATIVE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LIMIT OF DETECTION; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; RADIOIMMUNOASSAY; RELIABILITY; RISK FACTOR; VALIDATION PROCESS; BLOOD; IMMUNOLOGY; MIDDLE AGED; PROCEDURES;

ADOLESCENT; ADULT; AGED; AUTOANTIBODIES; CHILD; DIABETES MELLITUS, TYPE 1; DRIED BLOOD SPOT TESTING; FEMALE; HUMANS; INSULIN ANTIBODIES; MALE; MIDDLE AGED; RADIOIMMUNOASSAY;

EID: 84995511004     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0166213     Document Type: Article

References (31)

1. Atkinson MA, Eisenbarth GS, Michels AW. Type 1 diabetes. The Lancet. 2014; 383(9911):69-82. doi: 10.1016/s0140-6736(13)60591-7
2. Insel RA, Dunne JL, Atkinson MA, Chiang JL, Dabelea D, Gottlieb PA, et al. Staging Presymptomatic Type 1 Diabetes: A Scientific Statement of JDRF, the Endocrine Society, and the American Diabetes Association. Diabetes care. 2015; 38(10):1964-74. doi: 10.2337/dc15-1419 PMID: 26404926.
3. Ziegler AG, Rewers M, Simell O, Simell T, Lempainen J, Steck A, et al. Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children. JAMA: the journal of the American Medical Association. 2013; 309(23):2473-9. doi: 10.1001/jama.2013.6285 PMID: 23780460.
4. Rewers A, Dong F, Slover RH, Klingensmith GJ, Rewers M. Incidence of diabetic ketoacidosis at diagnosis of type 1 diabetes in Colorado youth, 1998-2012. JAMA: the journal of the American Medical Association. 2015; 313(15):1570-2. doi: 10.1001/jama.2015.1414 PMID: 25898057.
5. Cameron FJ, Scratch SE, Nadebaum C, Northam EA, Koves I, Jennings J, et al. Neurological consequences of diabetic ketoacidosis at initial presentation of type 1 diabetes in a prospective cohort study of children. Diabetes care. 2014; 37(6):1554-62. doi: 10.2337/dc13-1904 PMID: 24855156; PubMed Central PMCID: PMC4179516.
6. Lin A, Northam EA, Werther GA, Cameron FJ. Risk Factors for Decline in IQ in Youth With Type 1 Diabetes Over the 12 Years From Diagnosis/Illness Onset. Diabetes care. 2015; 38(2):236-42. doi: 10. 2337/dc14-1385 PMID: 25488913.
7. Semenkovich K, Bischoff A, Doty T, Nelson S, Siller AF, Hershey T, et al. Clinical presentation and memory function in youth with type 1 diabetes. Pediatric diabetes. 2015. doi: 10.1111/pedi.12314 PMID: 26377697; PubMed Central PMCID: PMCPMC4803626.
8. American Diabetes A. Standards of Medical Care in Diabetes-2016 Abridged for Primary Care Providers. Clin Diabetes. 2016; 34(1):3-21. doi: 10.2337/diaclin.34.1.3 PMID: 26807004.
9. Ziegler AG, Hummel M, Schenker M, Bonifacio E. Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes: the 2-year analysis of the German BABYDIAB Study. Diabetes. 1999; 48(3):460-8. PMID: 10078544.
10. Kupila A, Muona P, Simell T, Arvilommi P, Savolainen H, Hamalainen AM, et al. Feasibility of genetic and immunological prediction of type I diabetes in a population-based birth cohort. Diabetologia. 2001; 44(3):290-7. PMID: 11317658.
11. Barker JM, Barriga KJ, Yu L, Miao D, Erlich HA, Norris JM, et al. Prediction of autoantibody positivity and progression to type 1 diabetes: Diabetes Autoimmunity Study in the Young (DAISY). The Journal of clinical endocrinology and metabolism. 2004; 89(8):3896-902. doi: 10.1210/jc.2003-031887 PMID: 15292324.
12. Krischer JP, Lynch KF, Schatz DA, Ilonen J, Lernmark A, Hagopian WA, et al. The 6 year incidence of diabetes-associated autoantibodies in genetically at-risk children: the TEDDY study. Diabetologia. 2015; 58(5):980-7. doi: 10.1007/s00125-015-3514-y PMID: 25660258; PubMed Central PMCID: PMCPMC4393776.
13. Winkler C, Schober E, Ziegler AG, Holl RW. Markedly reduced rate of diabetic ketoacidosis at onset of type 1 diabetes in relatives screened for islet autoantibodies. Pediatric diabetes. 2012; 13(4):308-13. doi: 10.1111/j.1399-5448.2011.00829.x PMID: 22060727.
14. Elding Larsson H, Vehik K, Bell R, Dabelea D, Dolan L, Pihoker C, et al. Reduced prevalence of diabetic ketoacidosis at diagnosis of type 1 diabetes in young children participating in longitudinal follow-up. Diabetes care. 2011; 34(11):2347-52. doi: 10.2337/dc11-1026 PMID: 21972409; PubMed Central PMCID: PMC3198296.
15. Triolo TM, Chase HP, Barker JM, Group DPTS. Diabetic subjects diagnosed through the Diabetes Prevention Trial-Type 1 (DPT-1) are often asymptomatic with normal A1C at diabetes onset. Diabetes care. 2009; 32(5):769-73. doi: 10.2337/dc08-1872 PMID: 19407074; PubMed Central PMCID: PMC2671125.
16. Diabetes Prevention Trial-Type 1 Diabetes Study G. Effects of insulin in relatives of patients with type 1 diabetes mellitus. The New England journal of medicine. 2002; 346(22):1685-91. doi: 10.1056/ NEJMoa012350 PMID: 12037147.
17. Bonifacio E, Ziegler AG, Klingensmith G, Schober E, Bingley PJ, Rottenkolber M, et al. Effects of highdose oral insulin on immune responses in children at high risk for type 1 diabetes: the Pre-POINT randomized clinical trial. JAMA: the journal of the American Medical Association. 2015; 313(15):1541-9. doi: 10.1001/jama.2015.2928 PMID: 25898052.
18. Skyler JS, Krischer JP, Wolfsdorf J, Cowie C, Palmer JP, Greenbaum C, et al. Effects of oral insulin in relatives of patients with type 1 diabetes: The Diabetes Prevention Trial-Type 1. Diabetes care. 2005; 28(5):1068-76. PMID: 15855569.
19. Guthrie R, Susi A. A Simple Phenylalanine Method for Detecting Phenylketonuria in Large Populations of Newborn Infants. Pediatrics. 1963; 32:338-43. PMID: 14063511.
20. Demirev PA. Dried blood spots: analysis and applications. Analytical chemistry. 2013; 85(2):779-89. doi: 10.1021/ac303205m PMID: 23171435.
21. Bazzigaluppi E, Bonfanti R, Bingley PJ, Bosi E, Bonifacio E. Capillary whole blood measurement of islet autoantibodies. Diabetes care. 1999; 22(2):275-9. PMID: 10333945.
22. Siraj ES, Rogers DG, Gupta MK, Reddy SS. A simple screening method for individuals at risk of developing type 1 diabetes: measurement of islet cell autoantibodies (GADA, IA-2A, and IAA) on dried capillary blood spots collected on filter paper. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme. 2012; 44(11):855-60. doi: 10.1055/s-0032-1316349 PMID: 22893260.
23. Bingley PJ, Rafkin LE, Matheson D, Steck AK, Yu L, Henderson C, et al. Use of Dried Capillary Blood Sampling for Islet Autoantibody Screening in Relatives: A Feasibility Study. Diabetes technology & therapeutics. 2015; 17(12):867-71. doi: 10.1089/dia.2015.0133 PMID: 26375197; PubMed Central PMCID: PMCPMC4677115.
24. Dean BM, Becker F, McNally JM, Tarn AC, Schwartz G, Gale EA, et al. Insulin autoantibodies in the pre-diabetic period: correlation with islet cell antibodies and development of diabetes. Diabetologia. 1986; 29(5):339-42. PMID: 3522332.
25. Simell S, Hoppu S, Simell T, Stahlberg MR, Viander M, Routi T, et al. Age at development of type 1 diabetes-and celiac disease-associated antibodies and clinical disease in genetically susceptible children observed from birth. Diabetes care. 2010; 33(4):774-9. doi: 10.2337/dc09-1217 PMID: 20056952; PubMed Central PMCID: PMCPMC2845026.
26. Steck AK, Johnson K, Barriga KJ, Miao D, Yu L, Hutton JC, et al. Age of islet autoantibody appearance and mean levels of insulin, but not GAD or IA-2 autoantibodies, predict age of diagnosis of type 1 diabetes: diabetes autoimmunity study in the young. Diabetes care. 2011; 34(6):1397-9. doi: 10.2337/dc10-2088 PMID: 21562325; PubMed Central PMCID: PMC3114355.
27. Steck AK, Vehik K, Bonifacio E, Lernmark A, Ziegler AG, Hagopian WA, et al. Predictors of Progression From the Appearance of Islet Autoantibodies to Early Childhood Diabetes: The Environmental Determinants of Diabetes in the Young (TEDDY). Diabetes care. 2015; 38(5):808-13. doi: 10.2337/ dc14-2426 PMID: 25665818; PubMed Central PMCID: PMCPMC4407751.
28. Yu L, Robles DT, Abiru N, Kaur P, Rewers M, Kelemen K, et al. Early expression of antiinsulin autoantibodies of humans and the NOD mouse: evidence for early determination of subsequent diabetes. Proceedings of the National Academy of Sciences of the United States of America. 2000; 97(4):1701-6. doi: 10.1073/pnas.040556697 PMID: 10677521; PubMed Central PMCID: PMCPMC26499.
29. Wenzlau JM, Juhl K, Yu L, Moua O, Sarkar SA, Gottlieb P, et al. The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes. Proceedings of the National Academy of Sciences of the United States of America. 2007; 104(43):17040-5. doi: 10.1073/pnas.0705894104 PMID: 17942684; PubMed Central PMCID: PMCPMC2040407.
30. Bonifacio E, Yu L, Williams AK, Eisenbarth GS, Bingley PJ, Marcovina SM, et al. Harmonization of glutamic acid decarboxylase and islet antigen-2 autoantibody assays for national institute of diabetes and digestive and kidney diseases consortia. The Journal of clinical endocrinology and metabolism. 2010; 95(7):3360-7. doi: 10.1210/jc.2010-0293 PMID: 20444913; PubMed Central PMCID: PMCPMC2928900.
31. Schlosser M, Mueller PW, Torn C, Bonifacio E, Bingley PJ, Participating L. Diabetes Antibody Standardization Program: evaluation of assays for insulin autoantibodies. Diabetologia. 2010; 53(12):2611-20. doi: 10.1007/s00125-010-1915-5 PMID: 20871974.